BamSEC and AlphaSense Join Forces
Learn More

Carisma Therapeutics Inc.

NASDAQ: CARM    
Share price (1/8/25): $0.47    
Market cap (1/8/25): $19.8 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.6
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 61 pages Carisma Therapeutics Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 59 pages Carisma Therapeutics Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.0
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.0
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 8-K ~5 pages Warrant Amendment Agreement
12/34/56
EX-4.3
from 8-K ~5 pages Warrant Exercise Agreement
12/34/56
EX-4.2
from 8-K 7 pages Warrant Amendment Agreement
12/34/56
EX-4.1
from 8-K ~5 pages Warrant Exercise Agreement
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant Sesen Bio, Inc
12/34/56
EX-4.1
from 8-K 22 pages Common Stock Purchase Warrant Eleven Biotherapeutics, Inc
12/34/56
EX-4.2
from 8-K 21 pages Common Stock Purchase Warrant Eleven Biotherapeutics, Inc
12/34/56
EX-4.1
from 8-K 20 pages Pre-Funded Common Stock Purchase Warrant Eleven Biotherapeutics, Inc
12/34/56
EX-4.7
from S-1/A 19 pages Common Stock Purchase Warrant Eleven Biotherapeutics, Inc
12/34/56
EX-4.6
from S-1/A 18 pages Pre-Funded Common Stock Purchase Warrant Eleven Biotherapeutics, Inc
12/34/56
EX-4.7
from S-1/A 20 pages Eleven Biotherapeutics, Inc
12/34/56
EX-4.6
from S-1/A 20 pages Eleven Biotherapeutics, Inc
12/34/56
EX-4.1
from 8-K 20 pages Registration Rights Agreement
12/34/56